Business Context and Reporting Period
Company: American Battery Metals Corporation (formerly American Battery Technology Co)
Filing Type: Form 8-K (Current Report)
Report Date: December 3, 2020 (Earliest event reported: November 25, 2020)
Business Overview: The Company is engaged in the development of proprietary battery technology and capital asset acquisition. This filing reports on a private placement of equity securities and a material modification to the rights of security holders.
Key Financial Metrics and Capital Structure
Capital Raised:
- Total Units Sold: 29 Units in a private placement.
- Unit Price: $50,000 per Unit.
- Cash Proceeds: $1,050,000 received in this transaction (in addition to $1,250,000 reported on November 5, 2020).
- Debt Conversion: 8 Units issued in exchange for $400,000 of outstanding principal and interest on a convertible promissory note.
Security Composition (Per Unit):
- 5,000 shares of Series C Preferred Stock.
- Warrant to purchase 400,000 shares of Common Stock.
Warrant Terms:
- Exercise Price: $0.25 per share.
- Expiration: December 31, 2023.
- Redemption: Company may redeem at $0.001 per share if the Common Stock trades at or above $0.50 for 20 trading days prior to notice.
Use of Proceeds: General working capital, redemption of convertible notes, proprietary technology development, capital asset purchases, and ongoing business operations.
Material Changes and Corporate Actions
Unregistered Sales of Equity Securities (Item 3.02)
The Company completed a private placement of 29 Units to accredited investors under Section 4(a)(2) and Rule 506 of Regulation D. This transaction reduced outstanding debt by $400,000 and injected $1,050,000 in new cash liquidity.
Material Modification to Rights of Security Holders (Item 3.03)
On November 25, 2020, the Company issued 100,000 shares of Series A Convertible Preferred Stock to each of two newly appointed directors (Ryan Melsert and David Batstone).
- Voting Rights: Each share of Series A Preferred Stock carries 1,000 votes.
- Purpose: To grant voting control to current directors to facilitate efficient decision-making for the benefit of shareholders.
Guidance, Outlook, and Risks
Management Commentary: Management intends to utilize the net proceeds to fund the Company's business plan, specifically focusing on technology development and debt reduction. The issuance of high-vote preferred stock to directors is intended to streamline governance and operational speed.
Risks and Contingencies:
- Liquidity of Securities: The Units sold were not registered under the Securities Act of 1933 and may not be offered or sold in the U.S. absent registration or an applicable exemption.
- Dilution: The warrants provide for the potential issuance of significant common stock (up to 11.6 million shares from this tranche alone) at a fixed price of $0.25, subject to anti-dilution adjustments.
- Control Concentration: The issuance of Series A Preferred Stock with 1,000 votes per share significantly concentrates voting power with the two named directors.
Financial Outlook: The filing does not provide specific revenue, profit, or margin guidance. The filing text does not provide a clear value for current cash balances or total debt levels outside of the specific note conversion mentioned.
Investor Verification Checklist
- Verify the total aggregate cash raised from the private placement (current $1.05M + prior $1.25M) and confirm the remaining outstanding debt obligations.
- Review the Certificate of Designation for Series A Preferred Stock (Exhibit 3.1) to understand the full extent of director voting control.
- Assess the potential dilution impact of the 11.6 million warrant shares exercisable at $0.25 against the current market price of the Common Stock.
- Confirm the status of the registration statement for the warrant shares, as this affects the Company's ability to redeem the warrants.
- Examine the Company's cash burn rate and working capital needs to determine if the raised funds are sufficient for the stated technology development goals.